Trial Profile
Safety and efficacy of alendronate effervescent compared with alendronate tablet in postmenopausal women: A prospective observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2021
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Alendronic acid; Alendronic acid/colecalciferol
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2021 Results evaluating the persistence and eventual reasons for discontinuation in a cohort of PMW treated with ALN-EX and comparing persistence and reasons for discontinuation with a historical cohort from the same database treated with Fosamax/Fosavance, published in the Aging Clinical and Experimental Research
- 22 May 2018 New trial record
- 22 Apr 2018 Results assessing effect of alendronate on BMD and bone (n=96) presented at the 2018 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.